S'abonner navigation icon
FR
navigation icon menu icon S'abonner
navigation icon Accueil navigation icon Catalogue
icon language Langues navigation icon Menu
icon close
icon arrow

Rechercher

icon searchbar

Rechercher

Catalogue

icon close
icon close
icon close
icon language

Langues

icon close
background image
button download
icon share social
Category Janssen Announces Initiation Of Phase 3 Development Program For Sirukumab In Rheumatoid Arthritis
Lire
Lire

Janssen Announces Initiation Of Phase 3 Development Program For Sirukumab In Rheumatoid Arthritis

  • 2

    pages

  • English

  • Documents

Publié par
icon arrow

  • 2

    pages

  • English

  • Documents

Lire
Lire
icon

Description

Janssen Announces Initiation Of Phase 3 Development Program For Sirukumab In Rheumatoid Arthritis PR Newswire CORK, Ireland and SPRING HOUSE, Pennsylvania, Aug. 23, 2012 CORK, Ireland and SPRING HOUSE, Pennsylvania, Aug.
Voir icon arrow
icon success

Ajouté à mes notifications

Vous serez informé des prochaines publications.